On Monday, BioAffinity Technologies Inc (NASDAQ: BIAF) opened lower -6.83% from the last session, before settling in for the closing price of $0.81. Price fluctuations for BIAF have ranged from $0.80 to $3.62 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 13156.86% annually for the last half of the decade. Company’s average yearly earnings per share was noted 24.18% at the time writing. With a float of $9.45 million, this company’s outstanding shares have now reached $13.42 million.
In an organization with 75 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 31.85%, operating margin of -89.13%, and the pretax margin is -90.01%.
BioAffinity Technologies Inc (BIAF) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of BioAffinity Technologies Inc is 39.38%, while institutional ownership is 3.00%.
BioAffinity Technologies Inc (BIAF) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.18% per share during the next fiscal year.
BioAffinity Technologies Inc (NASDAQ: BIAF) Trading Performance Indicators
Check out the current performance indicators for BioAffinity Technologies Inc (BIAF). In the past quarter, the stock posted a quick ratio of 1.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.66 in one year’s time.
Technical Analysis of BioAffinity Technologies Inc (BIAF)
Let’s dig in a bit further. During the last 5-days, its volume was 0.73 million. That was better than the volume of 0.53 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 26.39%. Additionally, its Average True Range was 0.11.
During the past 100 days, BioAffinity Technologies Inc’s (BIAF) raw stochastic average was set at 5.33%, which indicates a significant decrease from 13.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.34% in the past 14 days, which was lower than the 110.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1182, while its 200-day Moving Average is $1.8474. However, in the short run, BioAffinity Technologies Inc’s stock first resistance to watch stands at $0.8265. Second resistance stands at $0.8982. The third major resistance level sits at $0.9765. If the price goes on to break the first support level at $0.6765, it is likely to go to the next support level at $0.5982. The third support level lies at $0.5265 if the price breaches the second support level.
BioAffinity Technologies Inc (NASDAQ: BIAF) Key Stats
There are currently 15,585K shares outstanding in the company with a market cap of 11.76 million. Presently, the company’s annual sales total 2,530 K according to its annual income of -7,940 K. Last quarter, the company’s sales amounted to 2,350 K and its income totaled -2,000 K.
